Promoter hypermethylation of death-associated protein kinase gene in cholangiocarcinoma.

作者: Xian-Ting Zhou , Shao-Ping Yu , Xiao-Fang Liu , Zheng Xu , Fan-Min Kong

DOI:

关键词:

摘要: Background Death-associated protein kinase (DAPK) is a Ca2+/calmodulin-regulated Ser/Thr which involved in apoptosis. The aberrant methylation of its promoter region CpG islands may be one the important mechanisms carcinogenesis. We studied relationship status and expression DAPK gene with clinical findings cholangiocarcinoma. Methods Target DNA was modified by sodium bisulfite, coverting all unmethylated, but not methylated, cytosines to uracil, subsequently detected methylation-specific PCR. Moreover, mRNA assessed RT-PCR. Results Aberrant 11 (30.6%) 36 tissue specimens cholangiocarcinoma, 2 (5.6%) adjacent normal tissues. expressed tumor tissues hypermethylation promoter. There were no statistical differences extent differentiation invasion, lymph node metastasis or pathologic type between methylated unmethylated Conclusions frequency cholangiocarcinoma high it offer an effective means for earlier auxiliary diagnosis malignancy. probably suppressed methylation, could become resistant apoptosis immunological surveillance. epigenetically affected associated carcinogenesis

参考文章(21)
Pilar Gonzalez-Gomez, M. Bello, Dolores Arjona, M. Alonso, Jesus Lomas, Jose De Campos, M. Kusak, Manuel Gutierrez, Jose Sarasa, Juan Rey, Aberrant CpG island methylation in neurofibromas and neurofibrosarcomas. Oncology Reports. ,vol. 10, pp. 1519- 1523 ,(2003) , 10.3892/OR.10.5.1519
Eunsil Yu, Jae Y. Ro, Seung-Mo Hong, Jene Choi, Kyueun Ryu, Promoter hypermethylation of the p16 gene and loss of its protein expression is correlated with tumor progression in extrahepatic bile duct carcinomas. Archives of Pathology & Laboratory Medicine. ,vol. 130, pp. 33- 38 ,(2006) , 10.1043/1543-2165(2006)130[33:PHOTPG]2.0.CO;2
S. Foja, M. Goldberg, U. Schagdarsurengin, R. Dammann, A. Tannapfel, W. G. Ballhausen, Promoter methylation and loss of coding exons of the fragile histidine triad (FHIT) gene in intrahepatic cholangiocarcinomas. Liver International. ,vol. 25, pp. 1202- 1208 ,(2005) , 10.1111/J.1478-3231.2005.01174.X
Mingzhou Guo, Michael G. House, Craig Hooker, Yu Han, Elizabeth Heath, Edward Gabrielson, Stephen C. Yang, Stephen B. Baylin, James G. Herman, Malcolm V. Brock, Promoter Hypermethylation of Resected Bronchial Margins: A Field Defect of Changes? Clinical Cancer Research. ,vol. 10, pp. 5131- 5136 ,(2004) , 10.1158/1078-0432.CCR-03-0763
A. Mazin Safar, Horace Spencer, Xiaobo Su, Maureen Coffey, Craig A. Cooney, Luke D. Ratnasinghe, Laura F. Hutchins, Chun-Yang Fan, Methylation Profiling of Archived Non–Small Cell Lung Cancer: A Promising Prognostic System Clinical Cancer Research. ,vol. 11, pp. 4400- 4405 ,(2005) , 10.1158/1078-0432.CCR-04-2378
W.-P. Qian, K. Dark, G. Toraldo, A. S. P. Lin, R. E. Guldberg, R. A. Flavell, M. N. Weitzmann, R. Pacifici, Y. Gao, Estrogen prevents bone loss through transforming growth factor β signaling in T cells Proceedings of the National Academy of Sciences of the United States of America. ,vol. 101, pp. 16618- 16623 ,(2004) , 10.1073/PNAS.0404888101
Xian-Ting Zhou, Xiao-Fang Liu, Zheng Xu, Shao-Jun Li, Shi-Guang Zhu, Hai-Long Su, Hao Zhang, The methylation status of the TMS1/ASC gene in cholangiocarcinoma and its clinical significance. Hepatobiliary & Pancreatic Diseases International. ,vol. 5, pp. 449- 453 ,(2006)
Xiao-Fang Liu, Sheng-Quan Zou, Xian-Ting Zhou, An analysis of 680 cases of cholangiocarcinoma from 8 hospitals. Hepatobiliary & Pancreatic Diseases International. ,vol. 4, pp. 585- ,(2005)
Sabine Zöchbauer-Müller, John D. Minna, Adi F. Gazdar, Shinichi Toyooka, Arvind K. Virmani, Eugene P. Frenkel, Alfredo J. Farinas, John McConnell, Kiyomi O. Toyooka, Riichiroh Maruyama, Aberrant Promoter Methylation Profile of Prostate Cancers and Its Relationship to Clinicopathological Features Clinical Cancer Research. ,vol. 8, pp. 514- 519 ,(2002)
Pankaj Singh, Tushar Patel, Advances in the diagnosis, evaluation and management of cholangiocarcinoma Current Opinion in Gastroenterology. ,vol. 22, pp. 294- 299 ,(2006) , 10.1097/01.MOG.0000218967.60633.64